282 Abstract INHIBITORS OF SPHINGOSINE KINASEThe invention relates to compounds of formula (I), where RI, R2, R3, R4, R5, R6, R7, R8,R9, R10, R11, R12, R13, R14, R15, R16, 17 nnnnK Ml, N-12, NI-3, N14, Y1, Y2, V, W, n, m and o havethe meanings specified herein, and to the physiologically compatible salts, derivatives, prodrugs, solvates, tautomers and stereoisomers thereof, including the mixtures thereof in all ratios, for use in the treatment of diseases that are influenced by inhibiting sphingosine kinase 1. No Figure